| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $179K | -51.5% |
| SG&A Expense | $5.1M | +35.9% |
| Operating Income | -$4.2M | +2.1% |
| Pre-tax Income | -$3.6M | +16.3% |
| Income Tax | -$18K | — |
| Net Income | -$4.0M | +22.9% |
| EPS (Basic) | -$3.54 | +87.2% |
| EPS (Diluted) | -$8.61 | -867.4% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $3.8M | +75.4% |
| Short-term Investments | $239K | +2.1% |
| Accounts Receivable | $134K | -6.3% |
| Current Assets | $6.0M | +76.7% |
| Total Assets | $20.4M | +273.4% |
| Current Liabilities | $1.4M | +60.8% |
| Total Liabilities | $4.7M | +424.1% |
| Stockholders' Equity |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$3.8M | -11.4% |
| Capital Expenditures | $14K | — |
| Investing Cash Flow | -$3.2M | -71.1% |
| Financing Cash Flow | $8.9M | +190.6% |
| Free Cash Flow | -$3.8M | — |
| $16.0M |
| +237.1% |